Trial Profile
Clinical Trials Insight: 700023889
Status:
Active, no longer recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 18 Jun 2007
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Folinic acid; Irinotecan; Tegafur/uracil
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Merck KGaA
- 18 Jun 2007 New trial record.